Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
Authors:
- Sung-Hsin KuoSKSung-Hsin Kuo
- Fu-Chang HuFHFu-Chang Hu
- Ann-Lii ChengACAnn-Lii Cheng
- Jin-Yuan ShihJSJin-Yuan Shih
- Chong-Jen YuCYChong-Jen Yu
- Chia-Chi LinCLChia-Chi Lin
- Tsu-Chen HuangTHTsu-Chen Huang
- Pan-Chyr YangPYPan-Chyr Yang
- Chih-Hsin YangCYChih-Hsin Yang
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 62 (3) , 334-343
Abstract
No abstract availableKeywords
Funding Information
- Department of Health, Government of Western Australia (NHRI-CN-CA9201S, NHRI-CN-CA9501S)
- Ministry of Education
- National Health Research Institutes (95R0066-BM01-02)
This publication has 51 references indexed in Scilit:
- ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung CancerJournal of Thoracic Oncology, 2007
- ERCC1 and Non–Small-Cell Lung CancerNew England Journal of Medicine, 2007
- Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapyAnnals of Oncology, 2007
- A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinomaBritish Journal of Cancer, 2006
- Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)The Lancet, 2005
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancerLung Cancer, 1998
- Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancerEuropean Journal of Cancer, 1992
- Activity of high-dose epirubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Phase II study of high-dose epirubicin in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990